» Articles » PMID: 36873345

Display of Multiple Proteins on Engineered Canine Parvovirus-like Particles Expressed in Cultured Silkworm Cells and Silkworm Larvae

Overview
Date 2023 Mar 6
PMID 36873345
Authors
Affiliations
Soon will be listed here.
Abstract

Recent progress has been made dramatically in decorating virus-like particles (VLPs) on the surface or inside with functional molecules, such as antigens or nucleic acids. However, it is still challenging to display multiple antigens on the surface of VLP to meet the requirement as a practical vaccine candidate. Herein this study, we focus on the expression and engineering of the capsid protein VP2 of canine parvovirus for VLP display in the silkworm-expression system. The chemistry of the SpyTag/SpyCatcher (SpT/SpC) and SnoopTag/SnoopCatcher (SnT/SnC) are efficient protein covalent ligation systems to modify VP2 genetically, where SpyTag/SnoopTag are inserted into the N-terminus or two distinct loop regions (Lx and L2) of VP2. The SpC-EGFP and SnC-mCherry are employed as model proteins to evaluate their binding and display on six SnT/SnC-modified VP2 variants. From a series of protein binding assays between indicated protein partners, we showed that the VP2 variant with SpT inserted at the L2 region significantly enhanced VLP display to 80% compared to 5.4% from N-terminal SpT-fused VP2-derived VLPs. In contrast, the VP2 variant with SpT at the Lx region failed to form VLPs. Moreover, the SpT (Lx)/SnT (L2) double-engineered chimeric VP2 variants showed covalent conjugation capacity to both SpC/SnC protein partners. The orthogonal ligations between those binding partners were confirmed by both mixing purified proteins and co-infecting cultured silkworm cells or larvae with desired recombinant viruses. Our results indicate that a convenient VLP display platform was successfully developed for multiple antigen displays on demand. Further verifications can be performed to assess its capacity for displaying desirable antigens and inducing a robust immune response to targeted pathogens.

Citing Articles

An Overview of Recent Developments in the Application of Antigen Displaying Vaccine Platforms: Hints for Future SARS-CoV-2 VLP Vaccines.

Utomo D, Suhaimi H, Azami N, Azmi F, Amin M, Xu J Vaccines (Basel). 2023; 11(9).

PMID: 37766182 PMC: 10536610. DOI: 10.3390/vaccines11091506.


Therapeutic Potential of Engineered Virus-like Particles of Parvovirus B19.

Sanchez-Moguel I, Montiel C, Bustos-Jaimes I Pathogens. 2023; 12(8).

PMID: 37623967 PMC: 10458557. DOI: 10.3390/pathogens12081007.

References
1.
Macek B, Forchhammer K, Hardouin J, Weber-Ban E, Grangeasse C, Mijakovic I . Protein post-translational modifications in bacteria. Nat Rev Microbiol. 2019; 17(11):651-664. DOI: 10.1038/s41579-019-0243-0. View

2.
Kwok A, Mentzer A, Knight J . Host genetics and infectious disease: new tools, insights and translational opportunities. Nat Rev Genet. 2020; 22(3):137-153. PMC: 7716795. DOI: 10.1038/s41576-020-00297-6. View

3.
Keeble A, Turkki P, Stokes S, Khairil Anuar I, Rahikainen R, Hytonen V . Approaching infinite affinity through engineering of peptide-protein interaction. Proc Natl Acad Sci U S A. 2019; 116(52):26523-26533. PMC: 6936558. DOI: 10.1073/pnas.1909653116. View

4.
Brown C, Feijlbrief M, van Lent J, Spaan W . Chimeric parvovirus B19 capsids for the presentation of foreign epitopes. Virology. 1994; 198(2):477-88. DOI: 10.1006/viro.1994.1059. View

5.
Utomo D, Pambudi S, Park E . Humoral immune response induced with dengue virus-like particles serotypes 1 and 4 produced in silkworm. AMB Express. 2022; 12(1):8. PMC: 8802989. DOI: 10.1186/s13568-022-01353-6. View